IQVIA reviewed 1,500+ launches (2010–2021), identifying traits that drive profitability, speed-to-break-even, and sustainable growth. A case study on an ADHD therapy highlighted success factors: strong differentiation, payer-aligned pricing, copay programs, and omnichannel engagement. Regional launches prioritized markets with favorable payer policies, scaling once formulary wins were secured. IQVIA’s five-step framework—strategy, access, education, infrastructure, and AI/ML-driven execution—helps emerging biopharmas overcome resource limits. The approach ensures faster uptake, stronger ROI, and resilient commercial strategies even in competitive and fragmented therapeutic markets.

Join for free to read